- Home
- ABOS vs RMBI Comparison
ABOS vs RMBI Comparison
Compare ABOS & RMBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABOS | RMBI |
|---|---|---|
| Founded | 1996 | 1887 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.5M | 134.3M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ABOS | RMBI |
|---|---|---|
| Price | $2.45 | $14.20 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 12.0K |
| Earning Date | 03-26-2026 | 01-22-2026 |
| Dividend Yield | N/A | ★ 4.19% |
| EPS Growth | N/A | ★ 27.17 |
| EPS | N/A | ★ 1.17 |
| Revenue | N/A | ★ $46,756,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $12.23 |
| Revenue Growth | N/A | ★ 8.95 |
| 52 Week Low | $0.86 | $11.37 |
| 52 Week High | $3.05 | $15.24 |
Technical Indicators
Market Signals| Indicator | ABOS | RMBI |
|---|---|---|
| Relative Strength Index (RSI) | 57.57 | 53.29 |
| Support Level | $2.21 | $13.72 |
| Resistance Level | $3.05 | $14.42 |
| Average True Range (ATR) | 0.32 | 0.28 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 53.88 | 72.86 |
Price Performance
Historical ComparisonAbout ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.
About RMBI Richmond Mutual Bancorporation Inc.
Richmond Mutual Bancorp Inc is a United States-based banking company. Its principal business consists of attracting deposits from the general public & brokered deposits and investing those funds predominantly in loans secured by commercial and multi-family real estate, first mortgages on owner-occupied, one-to four-family residences, a variety of consumer loans, direct financing leases, and commercial and industrial loans. The company has one reportable segment which is Community Banking.